JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3276
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.64B
| $1.9M | ﹤0.01% |
27,358
+5,400
| +25% | +$371K |
2017 Q3
7 quarters
|
|
3277
Interactive Brokers
IBKR
$41B
| $1.89M | ﹤0.01% |
142,960
+12,648
| +10% | +$171K |
2013 Q2
24 quarters
|
|
3278
Choice Hotels
CHH
$4.64B
| $1.89M | ﹤0.01% |
21,958
+10,578
| +93% | +$882K |
2014 Q3
19 quarters
|
|
3279
CALL
ICICI Bank
IBN
$101B
| $1.89M | ﹤0.01% |
+150,000
| New | +$1.74M |
2019 Q2
0 quarters
|
|
|
3280
PUT
ICICI Bank
IBN
$101B
| $1.89M | ﹤0.01% |
+150,000
| New | +$1.74M |
2019 Q2
0 quarters
|
|
|
MFA
3281
MFA Financial
MFA
$736M
| $1.89M | ﹤0.01% |
65,273
+3,511
| +6% | +$102K |
2013 Q2
24 quarters
|
|
3282
PUT
Omeros
OMER
$1.34B
| $1.89M | ﹤0.01% |
122,400
-26,100
| -18% | -$469K |
2019 Q1
1 quarter
|
|
3283
iShares US Healthcare Providers ETF
IHF
$1.38B
| $1.89M | ﹤0.01% |
55,195
-1,215
| -2% | -$40.4K |
2013 Q2
24 quarters
|
|
3284
Alamo Group
ALG
$1.97B
| $1.88M | ﹤0.01% |
18,921
+2,741
| +17% | +$274K |
2016 Q1
13 quarters
|
|
3285
Pacific Biosciences
PACB
$839M
| $1.88M | ﹤0.01% |
312,816
-562,894
| -64% | -$3.95M |
2017 Q4
6 quarters
|
|
3286
PUT
Check Point Software Technologies
CHKP
$13.5B
| $1.88M | ﹤0.01% |
16,300
-23,600
| -59% | -$2.79M |
2018 Q3
3 quarters
|
|
3287
Immersion
IMMR
$238M
| $1.88M | ﹤0.01% |
246,645
-493,223
| -67% | -$4.16M |
2017 Q4
6 quarters
|
|
|
ZYNE
3288
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $1.86M | ﹤0.01% |
+146,767
| New | +$1.69M |
2019 Q2
0 quarters
|
|
|
TNAV
3289
DELISTED
Telenav Inc.
TNAV
| $1.86M | ﹤0.01% |
235,899
-364,787
| -61% | -$2.54M |
2017 Q4
6 quarters
|
|
|
VIAB
3290
CALL
DELISTED
Viacom Inc. Class B
VIAB
| $1.86M | ﹤0.01% |
63,600
-100,000
| -61% | -$2.92M |
2018 Q3
3 quarters
|
|
3291
Marcus Corp
MCS
$815M
| $1.86M | ﹤0.01% |
56,855
+14,329
| +34% | +$527K |
2016 Q1
13 quarters
|
|
3292
PUT
Viking Therapeutics
VKTX
$3.61B
| $1.86M | ﹤0.01% |
222,100
-36,500
| -14% | -$312K |
2019 Q1
1 quarter
|
|
|
RRD
3293
DELISTED
RR Donnelley & Sons Co.
RRD
| $1.86M | ﹤0.01% |
920,659
+282,414
| +44% | +$933K |
2016 Q4
10 quarters
|
|
3294
KB Financial Group
KB
$43.8B
| $1.86M | ﹤0.01% |
47,027
+1,866
| +4% | +$72.8K |
2013 Q3
23 quarters
|
|
|
NGHC
3295
DELISTED
National General Holdings Corp
NGHC
| $1.86M | ﹤0.01% |
81,919
-2,401
| -3% | -$57.3K |
2015 Q2
16 quarters
|
|
3296
Westwood Holdings Group
WHG
$181M
| $1.85M | ﹤0.01% |
56,165
+6,941
| +14% | +$223K |
2017 Q4
6 quarters
|
|
3297
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.3B
| $1.85M | ﹤0.01% |
62,895
-5,800
| -8% | -$171K |
2015 Q4
14 quarters
|
|
3298
iShares US Utilities ETF
IDU
$1.41B
| $1.85M | ﹤0.01% |
24,652
+1,930
| +8% | +$143K |
2013 Q2
24 quarters
|
|
|
RTL
3299
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $1.85M | ﹤0.01% |
171,719
+95,298
| +125% | +$994K |
2018 Q4
2 quarters
|
|
|
HTBK
3300
DELISTED
Heritage Commerce
HTBK
| $1.85M | ﹤0.01% |
150,911
+30,899
| +26% | +$380K |
2016 Q4
10 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.